StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) income statement

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.51MP/E –Yield –

Achieve Life Sciences, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-257.7%

Financial strength

Current ratio
0.95
Debt to equity
–
Debt to assets
–
Cash to current liabilities
24.3%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

See a number that looks wrong?